Company news
- Home
- Information Centre
- Company news
- SBI China Capital acted as the Joint Bookrunner and Joint Lead Manager of the Global Offering of SHANGHAI HENLIUS BIOTECH INC. (2696.hk)
SBI China Capital acted as the Joint Bookrunner and Joint Lead Manager of the Global Offering of SHANGHAI HENLIUS BIOTECH INC. (2696.hk)
12.09.2019